Novel Eye Drop to Relieve Presbyopia Enters Phase 3 Clinicals

Orasis Pharmaceuticals, an Israeli based  ophthalmic pharmaceutical company announced the start of Phase 3 clinical studies in the US to...

Read More

SightRisk AMD Assessment Tool Makes North American Debut at VEW

SightRisk, a cloud-based AMD risk assessment tool, will launch to North America ECPs at Vision Expo West in Las Vegas on September 17, 2015 The...

Read More